Hostname: page-component-cd9895bd7-jn8rn Total loading time: 0 Render date: 2024-12-28T04:16:25.592Z Has data issue: false hasContentIssue false
  • English
  • Français

The Enterococcus

Published online by Cambridge University Press:  02 January 2015

Robert M. Gullberg
Robert M. Gullberg*
Affiliation:
Northwestern University Medical School, Section of Infectious Disease, Department of Medicine, Chicago, Illinois
*
Racine Medical Clinic, 5625 Washington Avenue, Racine, Wisconsin 53406
Get access Rights & Permissions [Opens in a new window]

Extract

In 1899, Thiercilin used the term “enterococcus” to describe microscopic organisms seen in pairs or short chains in feces. Later (in the 1930s) the name was used in a more restrictive sense for streptococci that had the hardy capacity to survive under extreme conditions.

Enterococci belong to a group D family of streptococci, as characterized by Lancefield in 1938. In contrast to other groups of streptococci, the group D antigen is not a wall carbohydrate but a glycerol teichoic acid containing glucose and D-alanine. This antigen appears to be related directly to the cytoplasm or plasma membrane.

Type
Special Sections
Information
Infection Control & Hospital Epidemiology , Volume 7 , Issue 12 , December 1986 , pp. 600 - 606
Copyright
Copyright © The Society for Healthcare Epidemiology of America 1986

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

1. Thiercelin, ME: C R Soc Biol 1899; 5:269.Google Scholar
2. Sherman, JM: Bact Review 1937; 1:3.Google Scholar
3. Braude, A, Davis, C, Fierer, J (eds): Infectious Disease and Medical Microbiology. Philadelphia, WB Saunders, 1985; p 250.Google Scholar
4. Wolfgang, Joklik W (eds): Zinsser Microbiology, 18 ed. New York, Appleton and Lang, 1984; pp 472–473.Google Scholar
5. Mandell, GL, Douglas, RG, Bennett, JE (eds): Principles and Practice of Infectious Diseases, ed 2. New York, John Wiley and Sons Inc, 1985, pp 1152–1155.Google Scholar
6. Moellering, RD, Korzeniowski, OM, Sande, MA, et al: Species-specific resistance to antimicrobial synergism in Streptococcus faecium and Streptococcus faecalis . J Infect Dis 1979; 140:203–208.CrossRefGoogle ScholarPubMed
7. Nowlan, SS, Deibel, RH: Group Q streptococci. I. Ecology, serology, physiology, and relationship to established enterococci. J Bact 1967; 94:291.CrossRefGoogle Scholar
8. Milgram, F, Flanagan, T (eds): Medical Microbiology. New York, Churchill, 1982; p 272–275.Google Scholar
9. Gross, KC, Houghton, MP, Senterfit, LB: Presumptive speciation of Streptococcus bovis and other group D streptococci from human sources by using arginine and pyruvate tests. J Clin Microbiol 1975; 1:54.Google Scholar
10. Mundt, JO: Occurrence of enterococci: Bud, bloom and soil studies. Appl Microbiol 1961; 9:541–544.Google Scholar
11. Langston, CW, Guttierez, J, Bauma, C: Motile enterococci (Streptococcus faecium van mobilus var. n) isolated from gross soilage. J Bact 1960; 80:714.Google Scholar
12. Graudal, H: The classification of motile streptococci within the enterococcus group. Acta Path Microbiol Scand 1957; 41:403.Google Scholar
13. Finegold, S, Martin, WJ (eds): Bailey and Scott's Diagnostic Microbiology, ed 6. St. Louis, CV Mosby, 1982, p 178.Google Scholar
14. Washington, JA II, Martin, WJ, Karlson, AG: Identification of bacteria, in Washington, JA II (ed): Laboratory Procedures in Clinical Microbiology. Boston, Little Brown & Co, 1974, pp 53–124.Google Scholar
15. Wilkowske, CJ: Enterococcal endocarditis. Mayo Clin Proc 1982; 57:101–105.Google ScholarPubMed
16. Deibel, RH: The group D streptococci. Bacterial Rev 1964; 28:330.Google Scholar
17. Brock, TD, Peacher, B, Pierson, D: Survey of the bacteriocines of enterococci. J Bact 1963; 86:702.Google Scholar
18. Levison, ME, Kaye, D: Fecal flora in man: Effect of cathartic. J Infect Dis 1969; 119:591–596.CrossRefGoogle ScholarPubMed
19. Mead, GC: in Skinner, FA, Quesnel, LB (eds): Streptococci. London, Academic Press, 1978, p 245. Google ScholarPubMed
20. Van der Wiel-korstanje, JAA, Winkler, KC: The fecal flora in ulcerative colitis. J Med Microbiol 1975; 8:491.Google Scholar
21. Nord, CE, Wadstrom, T: Characterization of hemolytic enterococci isolated from oral infections. Acta Odontol Scand 1973; 31:387.Google Scholar
22. Tefft, HI, Bibby, BG: Streptococci isolated from the mouth. J Dent Res 1940; 19:285.Google Scholar
23. Adhami, Z: The beta-lactamase activity of the vaginal flora of asymptomatic pregnant women. J Antimicrob Chemother 1982; 10:303–309.CrossRefGoogle ScholarPubMed
24. Koenig, GM, Kaye, D: Enterococcal endocarditis: Report of 19 cases with longterm follow-up data. N Engl J Med 1961; 264:257–264.Google Scholar
25. Kaye, D: Enterococci. Arch Intern Med 1982; 142:2006–2009.Google Scholar
26. Tomasz, A, Albino, A, Zanati, E: Multiple antibiotic resistance in a bacterium with suppressed autolytic system. Nature 1970; 227:138–140.Google Scholar
27. Gootz, TD, Sanders, CC, Sanders, WE: In vitro activity of furazlocillin (Bay K4999) compared with those of mezlocillin, piperacillin, and stable Betalactam antibiotics. Antimicrob Agents Chemother 1979; 15:783–791.CrossRefGoogle Scholar
28. Robinson, RG, Saunders, J, Cassel, R, et al: Comparative in vitro appraisal of piperacillin, including its activity against Salmonella. Antimicrob Agents Chemother 1980; 18:493–501.Google Scholar
29. Kuck, NA, Redin, GS: In vitro and in vivo activity of piperacillin: A broad spectrum semisynthetic penicillin. J Antibiot 1978; 31:33–41.Google Scholar
30. Tofte, RW, Solliday, J, Crossley, KB: Susceptibilities of enterococci to twelve antibiotics. Antimicrob Agents Chemother 1984; 25:532–553.CrossRefGoogle ScholarPubMed
31. Finland, M: Changing patterns of susceptibility of common bacterial pathogens to antimicrobial agents. Ann Intern Med 1972; 76:1009.CrossRefGoogle ScholarPubMed
32. Dickinson, GM, Cleary, TJ, Hoffman, TA: Comparative evaluation of piperacillin in vitro. Antimicrob Agents Chemother 1978; 14:919–921.Google Scholar
33. Reimer, LG, Mirrett, S, Reller, LB: Comparison of moxalactam (LY 127935) with cefazolin, amikacin, tobramycin, carbenicillin, piperacillin and ticarcillin against 420 blood culture isolates. Antimicrob Agents Chemother 1980; 17:412–416.Google Scholar
34. Verbist, L: In vitro activity of piperacillin: A new semisynthetic penicillin with an unusually broad spectrum of activity. Antimicrob Agents Chemother 1978;13:349–357.Google Scholar
35. Mandell, GL, Lindsey, E, Hook, EW: Synergism of vancomycin and streptomycin for enterococci. Am J Med Sci 1970;259:346–349.CrossRefGoogle ScholarPubMed
36. Standiford, HD, deMaine, JB, Kirby, WMM: Antibiotic synergism of enterococci: Relation to inhibitory concentrations. Arch Intern Med 1970;126:255–259.Google Scholar
37. Mandell, GL: Enterococcal endocarditis, in Kaye, D (ed): Infective Endocarditis. Baltimore, University Park Press, 1976, pp 101–110.Google Scholar
38. Moellering, RC Jr, Wennersten, C, Weinstein, AJ: Penicillin-tobramycin synergism against enterococci: A comparison with penicillin and gentamicin. Antimicrob Agents Chemother 1973;3:526–529.Google Scholar
39. Watanakunakorn, C: Penicillin combined with gentamicin or streptomycin: Synergism against enterococci. J Infect Dis 1971;124:581–586.Google Scholar
40. Zimmerman, RA, Moellering, RC Jr, Weinberg, AN: Mechanism of resistance to antibiotic synergism in enterococci. J Bacteriol 1971;105:873–879.Google Scholar
41. Bryan, CS, Reynolds, KL, Brown, JJ: Mortality associated with enterococcal bacteremia. Surg Gynecol Obstet 1985;160:557–561.Google Scholar
42. Garrison, RN, Fry, DE, Berberich, S, et al: Enterococcal bacteremia: Clinical implications and determinants of death. Ann Surg 1982;196:43–47.Google Scholar
43. Dougherty, S, Flohr, A, Simmons, RL: Breakthrough enterococcal septicemia in surgical patients: 19 cases and a review of the literature. Arch Surg 1983;118:232–237.CrossRefGoogle Scholar
44. Barrall, DT, Kenney, PR, Slotman, GJ, et al: Enterococcal bacteremia in surgical patients. Arch Surg 1985;120:57–63.Google Scholar
45. Shlaes, DM, Levy, J, Wolinsky, E: Enterococcal bacteremia without endocarditis. Arch Intern Med 1981;141:578–581.Google Scholar
46. Klimek, JJ, Ajemion, E, Gracewski, J, et al: Enterococcal infections in a large community hospital with emphasis on bacteremia. Am J Infect Control 1980;8:58–61.Google Scholar
47. Whiteside, M, Moore, J, Ratzam, K: An investigation of enterococcal bacteremia. Am J Infect Control 1983;11:125–129.Google Scholar
48. Mandell, GL, Kaye, D, Levison, ME, et al: Enterococcal endocarditis: Analysis of 38 patients observed at the New York Hospital-Cornell Medical Center. Arch Intern Med 1970;125:258–264.Google Scholar
49. Schoenbaum, SC, Gardner, P, Shillito, J: Infections of CSF shunts: Epidemiology, clinical manifestations and therapy. J Infect Dis 1975;131:543–553.Google Scholar
50. Ryan, JL, Pachner, A, Andriole, VT, et al: Enterococcal meningitis: Combined vancomycin and rifampin therapy. Am J Med 1980;68:449–451.Google Scholar
51. Bayer, AS, Seidel, JS, Yoshikawa, T, et al: Group D enterococcal meningitis. Arch Intern Med 1976;136:883–886.Google Scholar
52. Pitt, HA, Posstier, RG, Cameron, JL: Postoperative T-tube cholangiography. Ann Surg 1980;191:30–34.CrossRefGoogle ScholarPubMed
53. Morrow, DJ, Thompson, J, Wilson, SE: Acute cholecystitis in the elderly. Arch Surg 1978;113:1149–1152.CrossRefGoogle ScholarPubMed
54. Shimada, K, Inamatsu, T, Yamashiro, M: Anaerobic bacteria in biliary disease in elderly patients. J Infect Dis 1977;135:850–854.Google Scholar
55. Jackaman, FR, Triggs, CM, Thomas, V: Experimental bacterial infection of the biliary tract. Br J Exp Pathol 1980;61:369–375.Google Scholar
56. Blenkhorn, JI, Blumgart, LH: Streptococcal bacteremia in hepatobiliary operations. Surg Gynecol Obstet 1985;160:139–141.Google Scholar
57. Berk, SL, Verghese, A, Holtsclaw, SA, et al: Enterococcal pneumonia. Am J Med 1983;74:153–154.CrossRefGoogle ScholarPubMed
58. Sande, MA: Antimicrobial therapy for two serious bacterial infections: Enterococcal endocarditis and nosocomial pneumonia. Arch Intern Med 1982; 142:2033–2044.Google Scholar
59. Nolte, WA (ed): Oral Microbiology with Basic Microbiology and Immunology, ed4. St. Louis, CV Mosby, 1982, pp 298–300.Google Scholar
60. Lewis, JF, Johnson, P, Miller, P: Evaluation of amniotic fluid for aerobic and anaerobic bacteria. Am J Clin Pathol 1976;65:58–63.Google Scholar
61. Bavikatte, K, Schreiner, RL, Lemons, JA, et al: Group D streptococcal septicemia in the neonate. Am J Dis Child 1979;133:493–496.Google Scholar
62. Buchino, JJ, Ciambarella, E, Light, I: Systemic group D streptococcal infection in newborn infants. Am J Dis Child 1979;133:270–273.Google Scholar
63. Beargie, R, Lynd, P, Tucker, E, et al: Perinatal infection and vaginal flora. Am J Obstet Gynecol 1975;122:31–33.Google Scholar
64. Gross, PE, Harkavy, LM, Barden, GE, et al: The epidemiology of nosocomial enterococcal urinary tract infection. Am J Med Sci 1976;272:75–81.Google Scholar
65. Faro, S, Pastorek, J: The enterococcus: Myth or reality in ob/gyn infections. Infect Surg 1983;11:787–794.Google Scholar
66. Horvitz, R, Von Granenitz: A clinical study of the role of enterococci as sole agents of wound and tissue infections. Yale J Biol Med 1977;50:391–395.Google Scholar
67. Rantz, L, Kirby, W: Enterococci infections: An evaluation of the importance of fecal streptococcal and related organisms in the causation of human disease. Arch Intern Med 1943;17:516–528.Google Scholar
68. Freischlag, J, McGrattan, M, Busuttil, R: The clinical significance of enterococcus in surgical infections. Abstract #16. Presented at Surgical Infection Society, Florida, 1983.Google Scholar
69. Bartlett, J, Louie, T, Onderdonk, A, et al: Whither the enterococcus? Abstract #297. Interscience Conference Antimicrobial Agents and Chemotherapy, 1975.Google Scholar
70. Bartlett, JG, Onderdonk, AB, Louie, T, et al: A review: Lessons from an animal model of intra-abdominal sepsis. Arch Surg 1978;113:850–857.Google Scholar
71. Levison, ME: Peritonitis and intra-abdominal abscess, in Mandell, G, Douglas, RG, Bennett, JE (eds): Principles and Practice of Infectious Diseases. New York, John Wiley and Sons Inc, 1985.Google Scholar
72. Bohnen, JM, Matlow, A, Nohr, CW, et al: Pathogenicity of enterococcus in a rat model of fecal peritonitis. Abstract #276. Interscience Conference Antimicrobial Agents and Chemotherapy, 1983.Google Scholar
73. Crenshaw, C, Glanges, E, Webber, C, et al: A prospective random study of a single agent vs. combination antibiotics as therapy in penetrating inquiries of the abdomen. Surg Gynecol Obstet 1983;3:289–294.Google Scholar
74. Levison, ME, Santoro, J, Bran, JL, et al: In vitro activity and clinical efficacy of clindamycin in the treatment of infections due to anaerobic bacteria, abstracted. J Infect Dis 1977; 135:549.Google Scholar
75. Berne, TV, Yellin, AW, Appleman, MD, et al: Antibiotic management of surgically treated gangrenous or perforated appendicitis. Am J Surg 1982;144:8–13.Google Scholar
76. Yu, VL: Enterococcal superinfection and colonization after therapy with moxalactam, a new broad-spectrum antibiotic. Ann Intern Med 1981;94:784–785.Google Scholar
77. Chempakanallore, TT, Berk, S, Eapen, T: Enterococcal liver abscess associated with moxalactam therapy. Arch Intern Med 1983;143:1780–1781.Google Scholar
78. Marier, RL, Faro, S, Sanders, CV, et al: Moxalactam in the therapy of serious infections. Antimicrob Agents Chemother 1982;21:650–654.Google Scholar
79. Mickal, A, Carole, D, Lewis, C: Cefoxitin sodium: Double-blind vaginal hysterectomy prophylaxis in premenopausal patients. Obstet Gynecol 1980;56:222–225.Google Scholar
80. Ilstrup, DM: Organisms from blood cultures at the Mayo Clinic: 1968-1975, in Washington, JA (ed): The Detection of Septicemia. West Palm Beach, CRC Press, 1978, pp 23–25.Google Scholar
81. Beaman, KD, Kasten, BL, Gavan, RL: Rate of detection of bacteremia. Cleve Clin Q 1977;44:129–136.Google Scholar
82. Weinstein, MP, Reller, LB, Murphy, JR, et al: The clinical significance of positive blood cultures. A comprehensive analysis of 500 episodes of bacteremia and fungemia in adults—I. Laboratory and epidemiologic observations. Rev Infect Dis 1983;5:35–53.Google Scholar
83. Jones, R: Antibiotics in trauma. J Surg Pract 1977; September-October.Google Scholar
84. Ledger, WJ, Norman, M, Gee, C, et al: Bacteremia on an obstetric-gynecologic service. Am J Obstet Gynecol 1975;121:205–212.Google Scholar
85. Duma, RJ, Weinberg, AN, Medrek, TF, et al: Streptococcal infections. Medicine 1969;48:87–127.Google Scholar
86. Jarvinen, H, Renkonen, OV, Palmer, A: Antibiotics in acute cholecystitis. Ann Clin Res 1978;10:247–251.Google Scholar
87. Krieghley, MR: Preventing infection in biliary surgery. Infect Surg 1983;2:711–719.Google Scholar
88. Keighley, MR, Baddeley, RM, Burdon, DW: A controlled trial of parenteral prophylactic gentamicin therapy in biliary surgery. Br J Surg 1975;62:275–279.Google Scholar
89. Karran, S, Moore, PL, Goh, H: Three year experience with single dose cephalosporin prophylaxis in biliary surgery in: Controversies in Surgical Sepsis. Surgical Science Series. New York, Praeger Scientific, 1980, vol 1, pp 293–301.Google Scholar
90. Morris, DL, Mojaddedi, ZJ, Burdon, DW: Clinical and microbiological evaluation of piperacillin in elective biliary surgery. J Hosp Infect 1983;4:159–164.Google Scholar
91. Annual Summary—Nosocomial Infection Surveillance, 1983. MMWR 1984; 33(2SS):9SS–21SS.Google Scholar
92. Warren, JW, Tenney, JH, Hoopes, JM: A prospective microbiologic study of bacteriuria in patients with chronic indwelling urethral catheters. J Infect Dis 1982; 146:719.Google Scholar
93. Stamey, TA, Sexton, CC: The role of vaginal colonization with enterobacteriaceae in recurrent urinary infections. J Urol 1975; 113:214.Google Scholar
94. Harding, GKM, Ronald, AR: A controlled study of antimicrobial prophylaxis of recurrent urinary infection in women. N Engl J Med 1974; 291:597.CrossRefGoogle ScholarPubMed
95. Meares, EM, Barbalias, GA: Prostatitis: Bacterial, nonbacterial, and prostatodynia. Semin Urol 1983;1:149–150.Google Scholar
96. Fair, W, Couch, J, Wehner, N: Prostatic antibacterial factor—Identity and significance. J Urol 1976;76:169–177.Google Scholar
97. Berman, RS, Eiscle, JM: Bacteremia, spinal anesthesia and development of meningitis. Anesthesiology 1978;48:376–378.Google Scholar
98. Fox, J, Isenberg, HD: Antibiotic resistance of microorganisms isolated from root canals. Oral Surg 1967; 23:230.Google Scholar
99. Holden, HB, Durcan, DJ: Osteomyelitis of the maxilla. J Laryngol Otol 1963; 77:1021.Google Scholar
100. Mason, DA: Steroid therapy and dental infection: Case report. Br Dent J 1970; 122:271.Google Scholar
101. Falace, DA, Ferguson, TW: Bacterial endocarditis: Survey of patients between 1963 and 1975. Oral Surg 1976; 42:189.Google Scholar
102. Rahal, JJ, Meyers, BR, Weinstein, L: Treatment of bacterial endocarditis with cephalothin. N Engl J Med 1968; 279:1305–1309.Google Scholar
103. Carrizosa, J, Kaye, D: Antibiotic synergism in enterococcal endocarditis. J Lab Clin Med 1976; 88:132–141.Google Scholar
104. Serra, P, Brandimarte, C, Martino, P, et al: Synergistic treatment of enterococcal endocarditis: In vitro and in vivo studies. Arch Intern Med 1977; 137:1562–1567.Google Scholar
105. Wilkowske, CJ, Facklam, RR, Washington, JA II, et al: Antibiotic synergism: Enhanced susceptibility of group D streptococci to certain antibiotic concentrations. Antimicrob Agents Chemother 1971; 195–200.Google Scholar
106. Moellering, RC Jr, Wennersten, C, Medrek, T, et al: Prevalence of high level resistance to aminoglycosides in clinical isolates of enterococci. Antimicrob Agents Chemother 1970; 10:335–340.Google Scholar
107. Krogstad, DJ, Korfhagen, TR, Moellering, RC Jr, et al: Aminoglycoside inactivating enzymes in clinical isolates of Streptococcus faecalis: An explanation for resistance to antibiotic synergism. J Clin Invest 1978; 62:480–486.Google Scholar
108. Marder, HP, Kayser, FH: Transferable plasmids mediating multiple antibiotic resistance in Streptococcus faecalis subsp liquefaciens. Antimicrob Agents Chemother 1977; 12:267–269.Google Scholar
109. Krogstad, DK, Korfhagen, TR, Moellering, RC Jr, et al: Plasmid-mediated resistance to antibiotic synergism in enterococci. J Clin Invest 1978; 61:1645–1653.Google Scholar
110. Courvalin, PM, Shaw, WV, Jacob, AE: Plasmid-mediated mechanisms of resistance to aminoglycoside-aminocyclitol antibiotics and to chloramphenicol in group D streptococci. Antimicrob Agents Chemother 1978; 13:716–725.Google Scholar
111. Moellering, RC Jr, Murray, BE, Schoenbaum, SC, et al: A novel mechanism of resistance to penicillin-gentamicin synergism in Streptococcus faecalis . J Infect Dis 1980; 141:81–86.Google Scholar
112. Horodniceanu, T, Bougneleret, L, El-Solh, N, et al: High-level, plasmid-borne resistance to gentamicin in Streptococcus faecalis subsp zymogenes. Antimicrob Agents Chemother 1979; 16:686–689.Google Scholar
113. Yuv, V (mod): Enterococcus: An emerging pathogen, an overview. Infect in Surg 1984; (special supp), p 19.Google Scholar
114. Westenfelder, GO, Paterson, PY, Reisberg, BE, et al: Vancomycin-streptomycin synergism in enterococcal endocarditis. JAMA 1973; 223:37–40.Google Scholar
115. Hook, EW III, Johnson, WD Jr: Vancomycin therapy of bacterial endocarditis. Am J Med 1978; 65:411–415.Google Scholar
116. Cook, FV, Coddington, CC, Wadland, NC, et al: Treatment of bacterial endocarditis with vancomycin. Am J Med Sci 1978; 276:153–158.Google Scholar
117. Farber, BF, Moellering, RC Jr: Retrospective study of the toxicity of vancomycin from 1974–1981. Antimicrob Agents Chemother 1983; 23:138–141.Google Scholar
118. Gross, MH, Barriere, SL: Pathogenesis and treatment of enterococcal infections. Clin Pharm 1984; 3:161–166.Google Scholar